| INTRODUCTION
Contrast-induced acute kidney injury (CI-AKI) represents the most frequent systemic complication of coronary angiography and percutaneous coronary interventions (CA/PCI). 1 Despite its predominantly transient course, the onset of CI-AKI is associated with increased morbidity and mortality among patients with coronary artery disease (CAD). 2 The diagnosis of CI-AKI identifies high risk subjects requiring closer follow-up. Still, CI-AKI is frequently overlooked due to late serum creatinine concentration (SCr) increase, which is routinely utilized for CI-AKI diagnosis. 3 Numerous serum and urinary biomarkers have been proposed so far, but uncertainty exists concerning their clinical utility. 4 Different CI-AKI definitions and diverse study populations preclude direct comparison of different biomarkers. Large body of evidence supports the use of urinary neutrophil gelatinase-associated lipocalin (NGAL), 5, 6 however, little is known about the efficacy of other potential urinary biomarkers as an early CI-AKI biomarkers, especially in the setting of patients with preserved baseline kidney function. Urinary interleukin 18 (IL-18), 7 kidney injury molecule type 1 (KIM-1), 6 and liver fatty acidbinding protein (L-FABP) 6, 8 have been so far evaluated as potential disease markers, but to date none of the studies has unequivocally proved the superiority of a single marker for CI-AKI prediction.
The development of CI-AKI is inextricably connected with renal tubular hypoxia as a result of distorted equilibrium between vasoconstrictive and vasodilative agents. 9 The increased intra-renal vascular resistance is predominantly manifested in direct vasa recta, but it may also extend to arcuate and interlobular arteries. 10 Intra-renal Doppler flow parameters, most notably renal resistive index (RRI), reflect intra-renal hemodynamics and were shown to predict the onset and persistence of acute kidney injury, 11 as well as in-hospital mortality in intensive care setting. 12 Early estimation of RRI following contrast agent administration has not been assessed so far for the prediction of CI-AKI.
Thus, the study aimed to evaluate the diagnostic utility of urinary IL-18, KIM-1, and L-FABP assessed at 6 h following contrast administration, as well as Doppler-derived post-procedural indices of intra-renal blood flow at 1 h, for the prediction of CI-AKI in patients with CAD subject to CA/PCI.
| PATIENTS AND METHODS
This study is a part of a larger prospective investigation into the predictors of CI-AKI. The study design has been described previously. 13 Ninety-five patients with CAD were enrolled for the study between 2013 and 2015 following the analysis of baseline clinical and laboratory data, prior to urgent or elective referral for CA/PCI. The CI-AKI was defined as ≥50% relative or ≥0.3 mg/dL absolute increase of SCr at 48 h after procedure. 14 The research complied with the Declaration of Helsinki Guidelines. A valid permission for the study was granted by the local Ethics Committee. All patients signed a written informed consent prior to study enrollment. The renal Doppler-derived indices of blood flow in arcuate/ interlobular arteries were acquired directly before and 1 h after the procedure, using a 2-4 mm pulse-wave Doppler gate, by one trained physician using Vivid 7 (GE Healthcare) with a 5C probe (4.4-6.7 MHz).
The study was performed on patients in supine position, after 10 min of rest. Renal dimensions and potential abnormalities were evaluated and patients were screened for renal artery stenosis using peak systolic (PSV) and end-diastolic flow velocity calculation. The following intrarenal parameters were assessed: PSV and end-diastolic velocity (EDV), acceleration index (AI), acceleration time (AT), RRI, and renal pulsatility index (RPI). RRI was defined as RRI = (PSV-EDV)/PSV. RPI was defined as: RPI = (PSV-EDV)/MV, where MV stands for mean flow velocity.
The measurements were performed 3 times for each kidney during both pre-and post-procedural evaluation, and the final result represented an arithmetic mean.
Statistical analysis was calculated using MedCalc v.14. Pearson's and Spearman coefficient of correlation were also calculated. A P-value of less than 0.05 was regarded as statistically significant.
3 | RESULTS
| Baseline characteristics
Clinical characteristics of the study population have been previously described in detail. 13 The study covered 95 patients with CAD infarction. In brief, the population had high prevalence of obesity (41%), cigarette smoking (61%), diabetes mellitus or pre-diabetic states (39%), arterial hypertension (96%), and hyperlipidemia (93%). 13 The population was characterized by low-to-moderate CI-AKI risk with the Mehran risk score 15 of 7.5% (7.5; 14) . No significant sex-based differences were reported. Procedural data was highlighted in Table 1 .
Nine patients (9.5%) met the AKI Network criteria of CI-AKI. There 
| Inter-group differences
The analysis of pre-and peri-procedural risk factors was highlighted in a formerly published manuscript. 13 Of note, patients who developed CI-AKI were non-significantly older (median of 69 vs 65 years, P = 0.11), had higher SYNTAX score (median of 36 vs 11 points; P = 0.0002), and received higher dose of contrast media (median of 120 vs 100 mL, P = 0.049). 13 CI-AKI group was also characterized by higher rate of peripheral artery disease and a tendency toward higher rate of diabetes mellitus. 13 
| Urinary biomarker
Baseline urinary biomarker levels were comparable between CI-AKI and non-CI-AKI group (Table 2) . At 6 h following contrast administration, patients in CI-AKI group had significantly higher levels of urinary IL-18 and KIM-1, but not L-FABP (Table 2) . ΔIL-18 and ΔKIM-1 levels were significantly greater in CI-AKI than non-CI-AKI cohort, while ΔL-FABP remained comparable in both groups (Table 2) .
| Intra-renal Doppler flow indices
Patients with CI-AKI had significantly higher post-procedural RRI
and RPI values at 1 h after contrast administration (Table 2) .
ΔRRI and ΔRPI were comparable in both groups. Similarly to preprocedural values, patients with CI-AKI had substantially lower intrarenal EDV and comparable PSV at 1 h (Table 2) . Patients with CI-AKI had significantly greater value of AT at 1 h and ΔAT in comparison to non-CI-AKI group (Table 2 ). AI at 1 h was comparable in both groups, while ΔAI was significantly more negative in CI-AKI than non-CI-AKI group (Table 2) .
| ROC curve analysis
The | 467 onset ( Table 3 ). The results of the ROC curve analysis were depicted in 
| Urgent versus elective procedure
A detailed comparison of patients with ACS and stable angina was highlighted in Supplementary Table S1 . 
| DISCUSSION
In the current study we aimed to verify the hypothesis that urinary biomarkers and post-procedural intra-renal blood flow parameters 
FIGURE 1
Comparison of receiver operating characteristic curves of urinary IL-18-, KIM1-, L-FABP-to-creatinine ratios at 6 h, as well as RRI and RPI at 1 h, following contrast media administration for the prediction of CI-AKI. IL-18, interleukin 18-to-creatinne ratio; KIM-1, kidney injury molecule-1-to-creatinine ratio; L-FABP, liver-fatty acid-binding protein-to-creatinine ratio; RPI, renal pulsatility index; RRI, renal resistive index The reason for poor clinical utility of urinary L-FABP might be linked to the fact that roughly 1/3 of patients suffered from myocardial infarction. L-FABP was previously shown to be elevated in the aftermath of coronary incidents. 26 In the sub-analysis, patients with ACS exhibited a trend toward higher post-procedural, but not preprocedural L-FABP urinary level (Supplementary Table S1 ). Postprocedural KIM-1 was significantly higher in patients with ACS than stable angina cohort (Supplementary Table S1 ). These data raise doubts about the utility of urinary L-FABP and KIM-1 in cardiac catheterization setting, in favor of IL-18 use.
As far as vascular aspect is concerned, post-procedural RRI, and RPI at 1 h distinguished themselves with a perfect diagnostic power for the prediction of CI-AKI (AUC = 0.88 and 0.86, respectively). Postprocedural RRI value positively correlated with 48-h SCr ( Figure S2) and absolute SCr increase. Undoubtedly, the RRI and RPI values elevation was conditioned by markedly decreased intra-renal EDV in CI-AKI cohort in comparison to uneventful cases (Table 2 ). This is suggestive of increased renal vascular resistance associated with incipient CI-AKI, as shown by Doppler flow wire measurements, 27 leading to renal tubular hypoxia and apoptosis. The elevated RRI and RPI values in patients with CI-AKI seem to be accompanied by prolonged AT and decreased AI ( Table 2 ).
The clinical value of post-procedural RRI gains further importance in the context of its positive correlation with SYNTAX score ( Figure S1 ) and EMT, and negative correlation with baseline LVEF. As shown before, RRI could represent an indicator of diffuse arterial stiffness and cardiovascular risk factor, 28,29 predicting long-term morbidity and mortality. 12 
| STUDY LIMITATIONS
The amount of patients enrolled for the study is considerably low, 
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